“Nordic Life Science” partnering conference

Published on 06/09/2019

10-12 September, 2019
Malmö, Norway

ENYO Pharma will attend the Nordic Life Science Partnering conference in Mälmo to present its projects, technologies and partnering opportunities. At the same conference, ENYO will also participate in a panel discussion hosted by Charles River where several companies will share their experiences on fee for service partnering in drug discovery.

Read next in 'Events'

• The 2024 international workshop on Alport syndrome
• ENYO Pharma annonce un financement de Série C de 39 millions d'euros et l’autorisation de la FDA (IND) pour tester Vonafexor dans un essai clinique de Phase 2 pour les patients atteints du syndrome d'Alport
• 6th CKD Summit – Chronic Kidney Disease Drug Development
• ASN Kidney Week
• Alport Connect 2023, the annual Alport syndrome patient and family meeting in US